Literature DB >> 16909225

(124)I in PET imaging: impact on quantification, radiopharmaceutical development and distribution.

Andreas Bockisch, Lutz Freudenberg, Sandra Rosenbaum, Walter Jentzen.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16909225     DOI： 10.1007/s00259-006-0208-1

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  5 in total

1.  PET quantitation and imaging of the non-pure positron-emitting iodine isotope 124I.

Authors:  H Herzog; L Tellman; S M Qaim; S Spellerberg; A Schmid; H H Coenen
Journal:  Appl Radiat Isot       Date:  2002-05       Impact factor: 1.513

2.  Combined I-124 positron emission tomography/computed tomography imaging of NIS gene expression in animal models of stably transfected and intravenously transfected tumor.

Authors:  David Dingli; Brad J Kemp; Michael K O'Connor; John C Morris; Stephen J Russell; Val J Lowe
Journal:  Mol Imaging Biol       Date:  2006 Jan-Feb       Impact factor: 3.488

3.  Preparation of 124I solutions after thermodistillation of irradiated 124TeO2 targets.

Authors:  E J Knust; K Dutschka; R Weinreich
Journal:  Appl Radiat Isot       Date:  2000-02       Impact factor: 1.513

4.  Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET.

Authors:  Susanne M Eschmann; Gerald Reischl; Kilian Bilger; Juergen Kupferschläger; Marcel H Thelen; Bernhard M Dohmen; Hariolf Besenfelder; Roland Bares
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-03-27       Impact factor: 9.236

5.  Value of (124)I-PET/CT in staging of patients with differentiated thyroid cancer.

Authors:  L S Freudenberg; G Antoch; W Jentzen; R Pink; J Knust; R Görges; S P Müller; A Bockisch; J F Debatin; W Brandau
Journal:  Eur Radiol       Date:  2004-06-30       Impact factor: 5.315
  5 in total
  6 in total

1.  Optimization and assessment of quantitative 124I imaging on a Philips Gemini dual GS PET/CT system.

Authors:  Rebecca A Gregory; Claire A Hooker; Mike Partridge; Glenn D Flux
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-14       Impact factor: 9.236

Review 2.  Clinical applications of 124I-PET/CT in patients with differentiated thyroid cancer.

Authors:  Lutz S Freudenberg; Walter Jentzen; Alexander Stahl; Andreas Bockisch; Sandra J Rosenbaum-Krumme
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-12       Impact factor: 9.236

3.  Monte Carlo-based 3-dimensional dosimetry of salivary glands in radioiodine treatment of differentiated thyroid cancer estimated using 124I PET.

Authors:  R F Hobbs; W Jentzen; A Bockisch; G Sgouros
Journal:  Q J Nucl Med Mol Imaging       Date:  2013-03       Impact factor: 2.346

4.  Iodine-124 PET dosimetry in differentiated thyroid cancer: recovery coefficient in 2D and 3D modes for PET(/CT) systems.

Authors:  Walter Jentzen; Reiner Weise; Jürgen Kupferschläger; Lutz Freudenberg; Wolfgang Brandau; Ronald Bares; Wolfgang Burchert; Andreas Bockisch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-10       Impact factor: 9.236

5.  Monte Carlo modeling of cascade gamma rays in (86)Y PET imaging: preliminary results.

Authors:  Xuping Zhu; Georges El Fakhri
Journal:  Phys Med Biol       Date:  2009-06-12       Impact factor: 3.609

6.  The future of hybrid imaging-part 2: PET/CT.

Authors:  Thomas Beyer; David W Townsend; Johannes Czernin; Lutz S Freudenberg
Journal:  Insights Imaging       Date:  2011-02-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.